IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer-Reference-Cited by-同舟云学术

IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer

Published:2020-09-02 Issue:3 Volume:18 Page:391-403
ISSN:1547-6286
Container-title:RNA Biology
language:en
Short-container-title:RNA Biology

Author:

Bley Nadine¹^ORCID,Schott Annekatrin¹,Müller Simon¹,Misiak Danny¹^ORCID,Lederer Marcell¹,Fuchs Tommy¹,Aßmann Chris¹,Glaß Markus¹^ORCID,Ihling Christian²,Sinz Andrea²,Pazaitis Nikolaos³,Wickenhauser Claudia³^ORCID,Vetter Martina⁴,Ungurs Olga⁴^ORCID,Strauss Hans-Georg⁴,Thomssen Christoph⁴,Hüttelmaier Stefan¹

Affiliation:

1. Sect. Molecular Cell Biology, Inst. of Molecular Medicine, Charles Tanford Protein Center, Medical Faculty, Martin Luther University Halle-Wittenberg, Halle, Germany

2. Dept. of Pharmaceutical Chemistry & Bioanalytics, Inst. of Pharmacy, Charles Tanford Protein Center, Martin Luther University Halle-Wittenberg, Halle, Germany

3. Inst. of Pathology, Medical Faculty, Martin Luther University Halle-Wittenberg, Halle, Germany

4. Clinics for Gynecology, Medical Faculty, Martin Luther University Halle-Wittenberg, Halle, Germany

Funder

Wilhelm-Roux

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15476286.2020.1812894

Reference52 articles.

1. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer